Back to Directory

CBD

Cannabidiol

Visual ViewRaw DataInteraction Data

Meta Information

ID:cbd
Name:CBD
Schema Version:1.5

Title

CBD (Cannabidiol)

Alternate Names

  • Cannabidiol

Intervention Type

therapeutic_agent

Expected Cost Mean

Low Cost:
30
High Cost:
80
Cost Type:
monthly
Description:
Cost for daily use of a mid-potency tincture or capsule.

Summary

CBD is a non-psychoactive compound from the cannabis plant that interacts with the body's endocannabinoid system (ECS), a key regulator of homeostasis. Its relevance to healthspan is primarily through its potential to modulate inflammation, reduce anxiety, and improve sleep quality, all of which are foundational pillars of healthy aging. Unlike THC, it has low affinity for CB1 and CB2 receptors but influences the ECS through various other mechanisms.

Purpose

Modulates inflammation, anxiety, and sleep via the endocannabinoid system.

Card Summary

A non-psychoactive cannabis compound that may support healthspan by reducing inflammation and improving sleep.

Drug Class

Drugs In Class

Empty Array

Impact

Score:
4.2
Justification:
Indirect benefits via improved sleep, anxiety, and inflammation modulation.

Evidence

Grade:
B
Score:
5.5
Justification:
Human trials exist for specific conditions, but healthspan-specific data is limited.

Safety

Score:
3.8
Justification:
Generally well-tolerated but has potential for liver enzyme elevation and drug interactions.

Flags

  • Unregulated market can lead to inconsistent product quality and purity.
  • Can interact with medications, particularly blood thinners like warfarin and certain antidepressants.
  • High doses may cause elevated liver enzymes; monitoring is advised for long-term use.
  • Ensure product is THC-free if drug testing is a concern.

Verdict

Potentially useful for sleep and anxiety; direct healthspan evidence is limited.

Created

2026-04-23T22:58:46.266157Z

Model

Gemini 3.1 Pro (High)

Delivery

Route:
oral
Scope:
  • systemic

Indication

Focus:
healthspan
Description:
CBD is a non-psychoactive compound from the cannabis plant that interacts with the body's endocannabinoid system (ECS), a key regulator of homeostasis. Its relevance to healthspan is primarily through...

Typical Protocol

  • Start with 10-25 mg daily, titrating up as needed for sleep or anxiety.
  • Doses up to 300-600 mg have been used in clinical settings for specific conditions.